Abbott Laboratories (ABT) FY2025 Annual P&L / Income Statement
2025-01-01 to 2025-12-31
Revenue by Business Segment
2025-01-01 to 2025-12-31
Swipe to see the full flow
Chart details
Abbott Laboratories (ABT) FY2025 Annual P&L / Income Statement
Income statement for 2025-01-01 through 2025-12-31. View: Business segment. Revenue uses this breakdown; costs and expenses retain the consolidated categories.
- Net Sales
- 44,328,000,000 US dollars
- Cost of products sold, excluding amortization of intangible assets
- 19,319,000,000 US dollars
- Gross profit (calculated)
- 25,009,000,000 US dollars
- Operating expenses (calculated)
- 16,956,000,000 US dollars
- Operating Earnings
- 8,053,000,000 US dollars
- Other income (expense), net (calculated)
- 413,000,000 US dollars
- Earnings before Taxes
- 8,466,000,000 US dollars
- Taxes on Earnings
- 1,942,000,000 US dollars
- Net Earnings
- 6,524,000,000 US dollars
- Established Pharmaceuticals
- 5,536,000,000 US dollars
- Nutritionals
- 8,451,000,000 US dollars
- Diagnostics
- 8,937,000,000 US dollars
- Medical Devices
- 21,387,000,000 US dollars
- Amortization of intangible assets
- 1,682,000,000 US dollars
- Research and development
- 2,942,000,000 US dollars
- Selling, general and administrative
- 12,332,000,000 US dollars
- Revenue before reconciliation (calculated)
- 44,311,000,000 US dollars. Sum of the reported revenue categories before the separately reported reconciliation.
- Other
- 17,000,000 US dollars. Reported reconciliation to consolidated revenue.
- Established Pharmaceuticals costs (calculated)
- 4,246,000,000 US dollars. Segment revenue less segment operating income; it includes cost of revenue and operating expenses.
- Nutritionals costs (calculated)
- 6,893,000,000 US dollars. Segment revenue less segment operating income; it includes cost of revenue and operating expenses.
- Diagnostics costs (calculated)
- 7,197,000,000 US dollars. Segment revenue less segment operating income; it includes cost of revenue and operating expenses.
- Medical Devices costs (calculated)
- 14,175,000,000 US dollars. Segment revenue less segment operating income; it includes cost of revenue and operating expenses.
- Reconciling items (calculated)
- 3,764,000,000 US dollars. Segment revenue less segment operating income; it includes cost of revenue and operating expenses.
Chart connections
- Revenue less cost of revenue equals gross profit; gross profit less operating expenses equals operating income.
- Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit equals net income.
- Reported revenue categories plus the separately reported signed reconciliation equals consolidated revenue.

Free to share unchanged, with credit to Plicit.ai · CC BY-NC-ND 4.0Download PNG
Gross margin
56.4%
Gross profit / revenue
Operating margin
18.2%
Operating profit / revenue
Cash conversion
146.6%
Operating cash / net income, same period
Product waitlist
Health Check and Teardown for your own company
A health check uncovers insights of your private books, not a public ticker. Join this list to get notified as soon as we go-live!
